Boyd, R F
Boye, S L
Conlon, T J
Erger, K E
Sledge, D G
Langohr, I M
Hauswirth, W W
Komáromy, A M
Boye, S E
Petersen-Jones, S M
Bartoe, J T
Article History
Received: 19 November 2015
Revised: 19 February 2016
Accepted: 29 February 2016
First Online: 7 April 2016
Competing interests
: WWH and the University of Florida have a financial interest in the use of AAV therapies and own equity in a company (AGTC Inc.) that might, in the future, commercialize some aspects of this work. The remaining authors declare no conflict of interest.